Brodin, Petter http://orcid.org/0000-0002-8103-0046
Article History
Received: 1 May 2020
Accepted: 3 December 2020
First Online: 13 January 2021
Competing interests
: The author is a cofounder of Cytodelics AB, Stockholm, Sweden, and is scientific advisor for Scailyte AG, Zurich, Swizerland, and Kancera AB, Stockholm, Sweden.
Free to read: This content has been made available to all.